PROGNOSIS OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS WITH GRAVES' DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Objective: It is still controversial whether differentiated thyroid carcinoma (DTC) in patients with Graves' disease (GD) can be more aggressive than non-Graves' DTC. We conducted a systematic review and meta-analysis to examine the association between GD and prognosis in patients with DTC. Methods: We comprehensively searched the databases of MEDLINE and EMBASE from inception to March 2019. We included published studies that compared the risk of mortality and prognosis between DTC patients with GD and those with non-GD. Data from each study were combined using the random-effects model. Results: Twenty-five studies from February 1988 to May 2018 were included (987 DTC patients with GD and 2,064 non-Graves' DTC patients). The DTC patients with GD had a significantly higher risk of associated multifocality/multicentricity (odds ratio=1.45, 95% confidence interval: 1.04-2.02, I2=6.5%, p=0.381) and distant metastasis at the time of cancer diagnosis (odds ratio=2.19, 95% confidence interval: 1.08-4.47, I2=0.0%, p=0.497), but this was not associated with DTC-related mortality and recurrence/persistence during follow-up. Conclusion: Our meta-analysis demonstrates a statistically significant increased risk of multifocality/multicentricity and distant metastasis at the time of cancer diagnosis in DTC patients with GD than those without GD.